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SUMMARY 
 
The present product development project was aimed at studying the synergism 
and/or antagonism amongst various known insect repellent actives with the view 
to formulating a multi-active repellent product with improved properties when 
compared to current single-active commercial products. Advanced statistical 
methods were used to identify synergism between individual active substances 
and to define a formulation as close as possible to the “ideal” formulation. 
Several mosquito repellent samples were prepared and sent to the South African 
Bureau of Standards (SABS) in Pretoria to test for their efficiency in repelling 
mosquitoes.  
 
From the results of the repellency tests of the various active combinations, three 
actives were identified that showed promising signs of synergism. These actives 
were then studied in further detail to determine their optimum combination. In 
addition, it was shown that when using a natural flavourant as promoter and 
incorporating a slow-release agent into formulations for aerosols and lotions, a 
product is obtained that gives comparable levels of efficiency to current 
commercial products, but at much reduced levels of active loading. 
 
Accelerated stability tests performed on the final combination of the three actives 
used in the final formulation showed no adverse reactions over a three-week 
study. These tests shall be repeated once the final application form (lotion, 
aerosol, etc) and product packing have been decided. 
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PART A 
 
CHAPTER 1 
 
INTRODUCTION 
 
Each summer, outdoor loving people flock to their favourite destinations fully 
laden with the latest insect repellent products in order to prevent mosquitoes 
from biting. Besides the irritation of being bitten by mosquitoes, the threat of 
diseases such as Malaria, Yellow Fever and West Nile Virus is a constant 
concern to travellers worldwide. In addition to their potential health impact, 
insects such as mosquitoes can have a very significant economic impact on 
sectors such as the tourism industry.  
 
Commercially available insect repellents are virtually all based on single active 
components. The latter can be divided into two categories: synthetic chemicals 
and natural plant-derived essential oils [1]. Repellents containing synthetic 
chemicals often have side effects, which make their use at higher concentrations 
undesirable. Limiting the upper concentration levels of such active components 
naturally affects the efficacy of the final formulated product. In the case of 
repellents based on plant-derived essential oils like oil of citronella (a mixture of 
geraniol, citronellal, borneol, methylheptenone and acetic and valerianic acids), 
they are not sufficiently effective1, and high concentrations are required which 
may make their odour not well tolerated by users [2]. 
 
In view of the above considerations, there is a continual quest for the “perfect” 
topical mosquito repellent that is safe to use, effective and long lasting. During 
the 1940’s, in their search to provide an insect repellent composition that was 
able to repel a wide range of biting insects, Bernard Travis and Howard Jones [3] 
                                               
1 Effective: producing the intended result 
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found that an insect repellent composition containing more than one known 
active (dimethyl phthalate, 2-ethyl-1,3-hexanediol and n-butyl mesityl oxide 
oxalate) provides better repellency2 compared to compositions having a single 
active insect repellent. This observation is due to the additive effect of the 
actives, known as synergism. Synergism is the interaction of two or more agents 
so that their combined effect is greater than the sum of their individual effects. It 
originated from the Greek word sunergos meaning “working together” [4]. Despite 
this early evidence of synergism between insect repellent actives, it is rather 
surprising that very little has been described in the open and patent literatures 
that explores the possible synergism between such actives [3].  
 
The primary objective of this study was to investigate the existence, or otherwise, 
of synergism between a number of selected repellent actives. The motivation for 
undertaking such a study was that if a synergistic effect between multiple actives 
exists, it may be possible to not only reduce the total amount of active in the final 
product, but also the risks normally associated with single active mosquito 
repellents. A further advantage is the reduction in the costs of raw materials used 
in such formulations. 
 
This investigation will not include a study of the mechanism of synergism 
between the actives used in the mosquito repellent combination. 
 
1.1 BACKGROUND 
The outbreak of World War II and the need to conduct operations in areas where 
tropical diseases were common, led to the start of extensive investigations aimed 
at finding effective mosquito repellent actives. During these investigations, more 
than 4000 different compounds were screened for their efficacy in repelling a 
                                               
2 Repellency refers to a significant decrease in the number of insects probing or biting human 
skin where insect repellent has been applied compared with skin where repellent has not been 
applied. 
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variety of insects, including mosquitoes [5]. In the mid 1950’s, researchers in the 
USA discovered that N,N-diethyl-meta-toluamide (or DEET) was highly effective 
for repelling biting insects. DEET remains the most widely used synthetic insect 
repellent today, being the active ingredient in about 200 commercial insect 
repellent products [6]. 
 
Malaria, often referred to as the “silent killer”, is the world’s most serious tropical 
disease and imposes very significant economic costs (associated with 
preventative measures, treatment, loss of work hours, loss of income, etc.) on 
countries like South Africa. The direct and indirect cost in Africa is estimated to 
exceed R20 billion a year [7]. Each year in Africa, mosquitoes inject malaria 
parasites into humans billions of times. As a result, some 300 to 500 million full–
blown cases of malaria occur, and between 1 and 3 million people die. This is 
unlikely to be an accurate figure since most malaria deaths are not formally 
registered. It appears as though the malaria death toll rivals that of AIDS, which 
now kills about 3 million people annually [8]. Ninety percent of the deaths due to 
malaria occur in sub-Saharan Africa, and most are children under the age of five.  
 
During the year 2000, over 62 000 cases of malaria were recorded in South 
Africa. The most seriously affected area was Kwazulu-Natal, which recorded the 
worst malaria epidemic since 1931. Upon investigating the sudden epidemic, the 
mosquitoes collected were identified as Anopholes funestus, a species prevalent 
in southern Mozambique and eradicated in South Africa during the 1950’s [9]. 
The recent high rainfalls, the increase in labour migration, a reduction in the use 
of DDT and global warming are some of the factors said to be responsible for the 
sudden return of the Anopheles funestus mosquito [10]. Malaria is caused by the 
parasite of the genus plasmodium, which is carried by the female mosquito of the 
Anopheles species. Of the estimated 380 mosquito species in the genus 
Anopheles, only about 60 are able to transmit the malaria parasite to people.  
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Malaria transmission can be prevented or reduced through different control 
methods. The most direct and obvious precaution is to avoid getting bitten. 
Outdoor activities such as sports events, fishing and camping can become 
extremely unpleasant in areas where mosquitoes prevail. Consequently, 
mosquito repellents have occupied an important segment of the consumer health 
care market in many parts of the world. 
 
1.2 PREVENTATIVE MEASURES 
Attempts to control or even eradicate nuisance insects such as mosquitoes 
worldwide have been largely unsuccessful, and such an approach is 
environmentally questionable. Alternative methods of protection such as 
vaccination and preventative medication, while highly effective in certain cases, 
are very costly and only specific to any one type of disease. Insect repellents, on 
the other hand, have the advantage of providing protection against a variety of 
different insects, and hence also the transfer of disease. As a result, insect 
repellent products have developed into a very important sector of the consumer 
health market – not only because they are effective, but also because they are 
affordable. The main disadvantages of such products, however, are that they 
often only provide protection for limited time periods, thus requiring repeated 
application, and that the active ingredients, despite the use of fragrance 
materials, are often irritating to individuals. 
 
There are many different methods of preventing mosquitoes from biting. 
However, the focus of this work is on repellents, i.e., those substances applied to 
the skin that effectively prevent mosquitoes from biting. Protection from biting 
mosquitoes is best achieved by avoiding infested habitats, wearing protective 
clothing and using mosquito repellent products. However, in many 
circumstances, the latter protection method may be the only feasible way to 
protect against mosquito bites. While scientists may not fully understand how 
biting insects find their host, mosquitoes, the best studied of the biting insects, 
are known to use visual, thermal and olfactory stimuli to locate a blood meal [11]. 
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It is believed that mosquito repellent actives, such as DEET, prevent mosquitoes 
from landing and biting their host because the active disturbs the function of 
special receptors found on their antennae that sense chemicals excreted from 
the skin [12]. 
 
The application of natural, strong-smelling substances to the human skin to repel 
mosquitoes and other biting insects dates back to ancient Egyptian times. In the 
Roman history, we find references to the use of substances such as camphor, 
cypress, galbanum, lupin and cinnamon for the same purpose. Since then, many 
compounds have been tried and tested for repellence efficiency including garlic, 
olive oil, pennyroyal oil, raw tomato juice and many more. While some natural 
extracts are capable of providing some degree of protection against certain 
insect bites, they normally have a number of disadvantages: 
Ø They provide protection for very short periods of time; 
Ø They need to be used in very high concentrations in order to be effective; 
Ø They are not well tolerated by users (most have an unpleasant smell)[13]. 
 
As a result of these limitations, there has been an extensive effort from scientists 
and entrepreneurs to find the so-called “magic repellent compound”, i.e., a single 
compound that would not suffer from the above-mentioned shortcomings. While 
some very effective compounds have indeed been discovered (and are used 
extensively in repellent products today), they also do not fully circumvent these 
shortcomings. In addition, such compounds have brought along there own 
unique problems. 
 
In order to minimize inconsistencies in product performance testing of insect 
repellents, guidelines were set by the Environmental Protection Agency (EPA) in 
the United States [14]. Other requirements for an effective insect repellent 
against blood-feeding insects such as mosquitoes are: 
Ø Complete freedom from toxicity and irritation when applied regularly to a 
person’s skin; 
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Ø Cosmetic acceptability including freedom from unpleasant odour or touch, 
and harmless to clothing; 
Ø Protection against all biting mosquitoes; 
Ø Cost effectivity and ready availability [15].  
 
1.3 CURRENT TRENDS 
In an effort to repel mosquitoes, consumers spend large amounts of money 
annually on sprays, lotions, liquids, candles and personal mosquito repellers3. All 
modern repellent products contain an active ingredient, one or more solvents 
and, in most cases, a fragrance material to mask the unpleasant smell of the 
active ingredient. After application to the skin or other surface such as clothing, 
the solvents in the repellent evaporate, leaving a protective layer that interferes 
with the normal “scent” provided by the body. The repellent will then only be 
effective for as long as it takes the active component in the repellent to evaporate 
or be removed by other mechanisms such as washing, sweating, etc. Most 
repellent actives are high-boiling liquid compounds with boiling points above 
150oC, implying a low susceptibility to facile evaporation. 
 
The majority of effective insect repellent products on the consumer market 
contain DEET as the active ingredient. Despite its effectiveness, DEET has a 
number of disadvantages, namely: 
Ø It has a high potential to irritate eyes and mucous membranes; 
Ø It has a sticky, greasy feeling on the skin; 
Ø It has a strong, long lasting odour [13]. 
 
These negative attributes lead to instinctive rejection of DEET-containing 
products by many consumers. Products containing DEET are not recommended 
for continuous use or for use on infants since DEET is suspected of causing, 
amongst other medical conditions, meningitis. DEET has a strong solvent and 
                                               
3 Repellers refer to items such as wristbands impregnated with insect repellents. 
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plasticiser effect on many plastic items and lacquered surfaces, and can cause 
severe damage to glasses, watches and other synthetic materials used in 
clothing and accessories. In light of this, there is a significant demand for an 
effective mosquito repellent active that poses no adverse effects, i.e., a DEET-
free product  
 
In South Africa, almost all the synthetic mosquito repellent products contain 
DEET as the active ingredient, despite the possible health risks referred to 
above. Natural mosquito repellents tend to contain oil of citronella as the main 
repellent active. There are, however, a number of reports comparing data on the 
efficacy of such products with their synthetic alternatives. The results from such 
products tested under rigorous laboratory conditions have shown that claims of 
their effectiveness is severely over-rated. In most cases, such products: 
Ø Will work for disappointingly short periods, usually less than 2 hours; 
Ø Will only provide protection against some insects; 
Ø Will not protect against very aggressive insects, in particular mosquitoes; 
Ø Have to be used in such high concentrations that they may be even more 
irritating than their synthetic counterparts [16]. 
 
In this study, a number of currently available products (Tabard, Peaceful Sleep 
and Mylol) was obtained in order to determine the insect repellent active used in 
their product range and the quantity of active present (Table 1.1).  
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Table 1.1: Repellents in the South African marketplace 
 
 
Brand 
 
Product 
 
Active ingredient 
 
% Active 
Tabard Stick DEET 35 
 Lotion DEET 19.5 
 Candle Citronella 5 
 Towelletes Citronella 15 
 Aerosol DEET 15 
Peaceful Sleep Stick DEET 35 
 Aerosol DEET 15 
Mylol Lotion DEET, DMP, DBP 9, 57, 34 
 Aerosol DEET 15 
 Roll-on Citronella 15 
 
1.4 SUMMARY 
There is little doubt that insect repellent products are and will remain an 
important aid in preventing insect bites. There is, however, clear opportunities for 
improving such products to the benefit of the user and the manufacturer. This 
project will try and address some of these issues, which include inter alia: 
Ø Improving the efficacy of products; 
Ø Reducing the loading of actives in final products; 
Ø Increasing consumer satisfaction with product properties (odour, skin feel, 
etc); 
Ø Reducing the health risks associated with such products.  
 
As stated previously, this project will attempt to achieve some or all of these 
goals by evaluating the existence of synergism between various potential actives 
that may result in improved efficacy. We have also made a decision to 
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specifically exclude DEET as an active from these studies in view of the reported 
drawbacks associated with this compound. 
 
CHAPTER 2 
 
EXPERIMENTAL 
 
2.1 MATERIALS 
All reagents and solvents (Table 2.1) were obtained from commercial sources 
and were used as received.  
 
Table 2.1: Organic and inorganic reagents for synthesis, formulation and 
analytical procedures 
 
Reagents for 
Chemical 
name 
Source 
Grade/ 
purity 
Citronellal Sharon Bolel racemic 
Sulphuric acid Merck 98 % 
Sodium hydroxide Merck AR 
SYNTHESIS 
n-Heptane Merck AR 
Dimethyl phthalate Saarchem 97 % 
Benzyl benzoate Merck 98 % 
FORMULATION 
2-Butyl-2-ethyl-1,3-
propanediol 
Aldrich 99 % 
Methanol Merck HPLC 
ANALYSIS 
1,4-Dichlorobenzene Aldrich AR 
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2.2 PROCEDURE FOR THE SYNTHESIS OF p-MENTHANE-3,8-
DIOL  
Into a 3000 cm3 round bottom flask was charged 636 g (16.3 mmol) of a 0.25 wt 
% sulphuric acid solution. This mixture was heated to 550C, and citronellal (500 
g, 3.24 mol) was added dropwise over 1 hour whilst stirring the solution. The 
reaction mixture was maintained at 550C for 10 hours. Sodium hydroxide (8 g, 50 
mmol, 25 wt %) was then added, followed by 1200 cm3 of n-heptane, and the 
mixture stirred efficiently. The organic layer was removed and washed with 500 
cm3 of deionised water. The water layer was separated, and the organic layer 
refluxed under azeotropic conditions to remove residual water. The organic layer 
was then distilled at 800C under 1 mm Hg of pressure to give p-menthane –3,8-
diol (541.82g, 3.14 mol, 97% pure based on GC-peak area); EI-MS (m/e, relative 
intensity) 157 (M+-15.4), 154(M+-18.5), 139 (11), 121 (9), 111 (7), 96 (53), 81 
(100), 67 (18), 59 (62), 54 (23), 43 (34).  
 
2.3 PREPARATIONS OF FORMULATIONS 
Into a 100 cm3 beaker was weighed the required amount for the selected 
percentage ratio of each active ingredient to be included (see Tables 3.1 and 3.3) 
for each individual mixture. This mixture was heated at 500C until a clear liquid 
was obtained, and the required amount of commercial aqueous cream was then 
added to give a total sample mass as required. This mixture was efficiently mixed 
by stirring for 15 minutes.  
 
2.4 ANALYTICAL PROCEDURES 
2.4.1 GLC-Mass Spectrometry 
GLC-Mass spectrometry was performed on a Thermo Focus gas chromatograph 
coupled to a mass selector detector. The GLC was equipped with an RX-35 MS 
capillary column (30 m ´ 0.25 mm i.d.). Helium was used as the carrier gas with 
a flow rate of 40 cm3.min-1 at a column head pressure of 1.5 psi. Data from the 
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detector was analyzed by means of a personal computer with Xcaliber V3 
software. Details of the column temperature program are shown in Table 2.2. 
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Table 2.2:  GC-MS temperature program 
 
Parameter Setting 
Column initial temperature 700C 
Initial hold time 5 min 
Heating rate 100C.min-1 
Column final temperature 2700C 
Final hold time 5 min 
Injector temperature 2800C 
Detector temperature 2800C 
Detector solvent delay 1.2 min 
 
2.4.2 Capillary Gas Chromatography 
GLC analysis was performed on a Thermo Finnigan Gas Chromatograph 
equipped with a flame ionisation detector and a Supelco Alphadex-120 capillary 
column (30 m  ´ 0.25 mm i.d.). Data from the FID detector was analyzed by 
means of a personal computer equipped with DELTA Windows chromatography 
software. The carrier gas (N2) flow rate was 5 cm3.min-1 at a column head 
pressure of 10 psi. The split/splitless injector (model 1076) was operated at a 
split ratio of 1:70, and an injection volume of 1 µL was used. Samples were 
injected with the aid of an auto-injector (model A1 3000). Details of the column 
program used are shown in Table 2.3.  
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Table 2.3: GLC temperature program 
 
Parameters Setting 
Column initial temperature 700C 
Initial hold time 1 min 
Program rate 100C.min-1 
Column final temperature 2700C 
Final hold time 5 min 
Injector temperature 2500C 
Detector temperature 2800C 
 
The internal standard method was used for all quantitative work with the internal 
standard being 1,4-dichlorobenzene. Response factors for the components of 
interest were determined by means of three calibration injections with known 
masses of standards and internal standard, prior to analysis. 
 
This mode of operation was mainly used to determine the purity of citronellal and 
p-menthane -3,8-diol. 
 
2.5 EFFICACY TESTING PROCEDURES 
In accordance with the relevant method in Section 4 of SABS Method 807, yellow 
fever (Aedes aegypti) mosquitoes approximately 7-14 days old were deprived of 
a blood meal for >96 hours and then used as the test insects. The following 
equipment was also utilised for the repellency tests: 
Ø Wooden test cages 300 mm high, 300 mm wide, 450 mm long and with 
sides covered with nylon mosquito netting, one side having a sleeve-inlet 
(Illustration 1); 
Ø Plastic tubes 200 cm3 with a diameter of approximately 60 mm and height 
80 mm, and covered with nylon mosquito netting on both ends (Illustration 
2).  
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The wooden test cages that were used were prepared 24 hours before 
commencement of the repellency test, and contained 100 mosquitoes; the 200 
cm3 plastic tube contained 30 mosquitoes and was prepared an hour before. As 
a food source, cotton wool was soaked in a 5 % sugar solution and placed inside 
the test cages and plastic tubes. 
 
The selected volunteer’s forearm was washed thoroughly with unscented soap 
and water to remove any traces of perfume. As a control to determine if the 
mosquitoes and arms used for the test were normal, one arm of each volunteer, 
chosen at random by the test officer, was placed inside a wooden cage 
containing 100 mosquitoes. Once 10 mosquitoes had landed, the time was 
recorded and the arm withdrawn from the cage. The norm used is that at least 10 
landings should be recorded within a 30 second period. The hand of the 
volunteer was covered with a latex glove during the control test (Illustration 3). 
 
Each volunteer’s forearm was divided into three areas by drawing a line with a 
pen at the borders of each area. These areas were treated liberally with a 
numbered sample. The areas were treated by applying the sample first to the left 
arm area closest to the hand, the area next to this treated second, and so on, 
with the last treatment being closest to the right hand. After a fifteen-minute wait, 
either a plastic tube was placed on the treated area (Illustration 4) or the arm was 
exposed to the test cage (Illustration 5) for a five-minute period. The number of 
bites obtained during the five-minute period was recorded, and only those treated 
areas where five or less bites were recorded were re-exposed hourly for up to 5 
hours.  
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Illustration 1: Test cage containing 100 mosquitoes 
 
 
 
 
Illustration 2: Containing the 30 test mosquitoes  
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Illustration 3: Control test 
 
 
 
Illustration 4: Treated area covered with the tube containing 30 
mosquitoes 
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Illustration 5: Treated area placed inside cage containing 100 
mosquitoes 
 
 
 
 
2.6 PROCEDURE FOR STABILITY TESTING 
Three samples (Sample 1, Sample 2, and Sample 3) each containing 30 g of 
insect repellent actives, were made up in the following ratio:  
 
p-Menthane-3,8-diol:  70 % 
Benzyl benzoate:  15 % 
2-Butyl-2-ethyl-1,3- propanediol:  15 % 
 
The mosquito repellent actives were combined together into beakers and stirred 
for 10 minutes whilst purging with nitrogen gas. Three temperature settings were 
used in the stability tests, namely 26, 38 and 580C. For each of these three 
temperature settings, approximately 10 cm3 of the mosquito repellent 
combination labelled Sample 1, Sample 2 and Sample 3 was placed into glass 
vials and sealed with plastic lids.  
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To ensure that the temperature remained constant, the temperature within the 
incubators was monitored weekly, using a standard 1200C mercury thermometer.  
 
Each week, an approximately 2 cm3 sample was collected from each of the glass 
vials stored in the incubators, and these analysed on the GC-MS as 0.6 % 
methanol solutions.  
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CHAPTER 3 
 
RESULTS AND DISCUSSION 
 
3.1 REPELLENCY TESTS 
Four known and approved insect repellent actives were combined in different 
proportions in an attempt to determine if synergism exists between any two or 
more of the actives. Three of the four actives used are so-called synthetic 
compounds, not being available from natural sources. They were dimethyl 
phthlate, benzyl benzoate and 2-butyl-2-ethyl-1,3-propanediol. All of these 
actives have individually been reported to possess some degree of repellent 
action against various biting insects [15]. 
 
During the latter days of World War II, clothing was impregnated with dimethyl 
phthalate (DMP), or preparations containing dibutyl phthlate (DP) and benzyl 
benzoate as a means of repelling insects. Another product referred to as M-1960 
was developed by the U. S. Army to meet their needs for protection against a 
broad spectrum of arthropod vectors4 and diseases, and consisted of equal parts 
N-butylacetanilide, 2-butyl-2-ethyl-1,3-propanediol and benzyl benzoate [17]. 
 
The fourth active, para-menthane-3,8-diol (PMD or Quwenling), is a naturally 
occurring insect repellent used extensively in China since 1978. It occurs in small 
quantities in the leaves of Eucalyptus trees but can be synthesized from 
citronellal, one of the main constituents of citronella, an essential oil distilled from 
the leaves and stem of the Cymbopogon nardus plant [18].  
 
Due to the high costs involved in repellency testing, only four samples containing 
varying amounts of the four selected insect repellent actives were evaluated to 
                                               
4 Arthropod vectors: disease-carrying insects for example mosquitoes. 
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determine if, in fact, they repelled mosquitoes. Once these results were obtained, 
more samples were formulated according to a specific mixture design, and sent 
for repellency testing. The results were statistically analysed and the best 
combination of actives identified.  
 
Table 3.1 contains the details of the first batch of samples that was sent to the 
SABS Test House in Pretoria for preliminary repellency testing. Four different 
active combinations were prepared for these tests; each sample contained a total 
of 10 % (m/m) active (Table 3.1). Using the plastic tubes containing 30 female 
mosquitoes each, the treated areas were exposed for a 5-minute period only, to 
determine if a particular combination repelled mosquitoes. No bites were 
received for any of the samples during the 5-minute period and it was therefore 
possible to conclude that the four different combinations prepared did in fact 
repel mosquitoes (Table 3.2). 
 
Table 3.1: Preliminary samples: Active loadings 
 
 
No. 
 
p-Menthane-
3,8-diol 
Dimethyl 
phthlate 
Benzyl 
benzoate 
2-Butyl-2-
ethyl-1,3-
propanediol 
Aqueous 
cream 
1 5 % 
(0.9945 g) 
5 % 
(1.0169 g) 
0 0 90 % 
(18.7272 g) 
2 5 % 
(0.9964 g) 
0 5 % 
(0.9512 g) 
0 90 % 
(18.2614 g) 
3 5 % 
(0.9520 g) 
0 0 5 % 
(0.9560 g) 
90 % 
(19.6458 g) 
4 5 % 
(0.5139 g) 
2.5 % 
(0.5102 g) 
2.5 % 
(0.5102 g) 
2.5 % 
(0.5614 g)  
90 % 
(19.0090 g) 
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Table 3.2: Number of bites recorded during 5-minute exposure period 
 
Sample No. No. of bites 
1 NONE 
2 NONE 
3 NONE 
4 NONE 
 
In view of the promising preliminary results obtained, it was decided to use 
statistical experimental design to establish unequivocally whether any synergism 
existed between any of the actives and also to obtain some indication as to the 
optimum ratios such actives should be combined in.  
 
3.2 INTRODUCTION TO MIXTURE DESIGNS 
Virtually all consumer products are mixtures of two or more ingredients. In all 
such cases, one or more particular properties of a specific consumer product are 
of particular importance to the user. For example, in the case of the headache 
tablet, properties such as the speed of action and the length of action may be 
important. The properties (effect) of mixtures/products are a direct result of: 
Ø The type of ingredients; and  
Ø The relative amounts (proportions) of the ingredients contained in the 
product.  
 
Both the type and the relative amount of ingredients can profoundly influence the 
property or effect of a particular mixture. For example, a very effective herbicide 
(weed killer) may be practically useless if it cannot “wet” the surface of weed 
leaves. A surfactant may be used to aid the wetting process, thereby enhancing 
the effect of the herbicide chemical considerably. For existing products, the type 
of ingredients is normally fixed and the only way to enhance desirable properties, 
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or to mask undesirable properties, is to vary the relative proportions of the 
individual ingredients. Naturally, for new mixtures/products, the type of ingredient 
as well as the relative amounts of ingredients can be chosen to give the most 
desired effect. 
 
The process of finding the best combination of proportions of ingredients is often 
a tedious one, carried out by persons with many years of practical experience in 
the particular field. When such experience is not available, the optimisation 
process often takes the form of trial and error, or “scatter-gun” procedures. These 
procedures are not only expensive in terms of time and materials, but result in 
considerable uncertainty in terms of whether the best possible combination has 
actually been achieved.  
 
However, the experimental design procedures used in this study, which were first 
introduced in 1958 by Scheffé, are not only able to cover the entire range of 
possible combinations of components, but can also evaluate the best ratios in 
which the most promising components should be combined in [19]. 
 
3.3 DETAILS OF THE MIXTURE DESIGN USED 
For the purposes of this investigation, a Simplex Centroid design in four factors 
was used. Five of the combinations were replicated in order to obtain an estimate 
of the experimental error in the efficacy test. The design (in coded format) is 
shown in Table 3.3. 
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Table 3.3: Simplex Centroid design used 
 
Std 
p-Menthane-
3,8-diol 
Dimethyl 
phthlate 
Benzyl 
benzoate 
2-Butyl-2-ethyl-
1,3-propanediol 
1 1 0 0 0 
2 0 1 0 0 
3 0 0 1 0 
4 0 0 0 1 
5 0.5 0.5 0 0 
6 0.5 0 0.5 0 
7 0.5 0 0 0.5 
8 0 0.5 0.5 0 
9 0 0.5 0 0.5 
10 0 0 0.5 0.5 
11 0.33 0.33 0.33 0 
12 0.33 0.33 0 0.33 
13 0.33 0 0.33 0.33 
14 0 0.33 0.33 0.33 
15 0.25 0.25 0.25 0.25 
16 0.62 0.12 0.12 0.12 
17 0.12 0.62 0.12 0.12 
18 0.12 0.12 0.62 0.12 
19 0.12 0.12 0.12 0.62 
20 0 0 0 1 
21 1 0 0 0 
22 0 1 0 0 
23 0 0 1 0 
24 0.5 0 0 0.5 
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Details of the actual amounts of actives and commercial aqueous cream that 
were mixed to give the combinations specified by the above design are given in 
Table 3.4. Table 3.4 also gives a “score” for each formulation and the “run” refers 
to the actual sample number. The score figures will now be explained. Due to the 
large number of samples, twelve volunteers were used during the repellency 
testing. Each sample was replicated four times using a different individual in 
order to average (or allow for) the expected difference in response, resulting from 
the natural difference between the individuals used. Each individual’s treated 
area was exposed to a test tube containing 30 mosquitoes, and once an 
accumulated amount of five bites had been received, the test was terminated for 
that sample. The result is that for some individuals the test was terminated before 
other individuals, which made interpretation of the results somewhat difficult. In 
the case of this design, it was therefore decided to evaluate the results as 
follows. Whenever a test was terminated for an individual, an arbitrary number of 
bites (15) were allocated to those times for which the sample was not tested. The 
total number of bites over a four-hour period for each sample was then added 
together and averaged over the four individuals. In so doing, the difference 
between individuals was “naturally” incorporated into the final evaluation, and the 
evaluation could be performed over a constant test period, namely four hours.  
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Table 3.4: Design composition details 
 
S
td
 
R
un
 
S
co
re
 p-Menthane-
3,8-diol 
Dimethyl 
phthlate 
Benzyl 
benzoate 
2-Butyl-2-
ethyl-1,3-
propanediol 
Aqueous 
cream 
16 1 31 6.25 % 
(3.1109 g) 
1.25 % 
(0.626 g) 
1.25 % 
(0.6291 
1.25 % 
(0.6276 g) 
90 % 
(44.7321 g) 
3 2 272 0 
 
0 10 % 
(5.0096 
0 90 % 
(44.6462 g) 
8 3 138 0 5 % 
(2.4631 
5 % 
(2.5349) 
0 
 
90 % 
(44.7443 g) 
13 4 64 3.33 % 
(1.6602 g) 
0 3.33 % 
(1.6617 
3.33 % 
(1.6575 g) 
90 % 
(44.752 g) 
24 5 29 5 % 
(2.5109 g) 
0 0 5 % 
(2.4905 g) 
90 % 
(45.2769 g) 
7 6 102 5 % 
(2.5057 g) 
0 0 5 % 
(2.4905 g) 
90 % 
(45.2769 g) 
12 7 123 3.33 % 
(1.6521 g) 
3.33 % 
(1.657 g) 
0 3.33 % 
(1.6499 g) 
90 % 
(46.3701 g) 
2 8 174 0 10 % 
(5.0114 
0 0 90 % 
(45.0589 g) 
23 9 296 0 0 10 % 
(5.0114 
0 90 % 
(45.0589 g) 
10 10 89 0 0 5 % 
(2.4922 
5 % 
(2.4693 g) 
90 % 
(46.725 g) 
9 11 126 0 5 % 
(2.5012 
0 5 % 
(2.4878 g) 
90 % 
(46.725 g) 
14 12 184 0 3.33 % 
(1.6819 
3.33 % 
(1.6779 
3.33 % 
(1.6631 g) 
90 % 
(43.9579 g) 
15 13 99 2.5 % 
(1.2615 g) 
2.5 % 
(1.2672 
2.5 % 
(1.2631 
2.5 % 
(1.2513 g) 
90 % 
(44.5637 g) 
11 14 131 3.33 % 
(1.6600 g) 
3.33 % 
(1.6557 
3.33 % 
(1.6573 
0 90 % 
(45.2657 g) 
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17 15 141 1.25 % 
(0.6400 g) 
6.25 % 
(3.1194 
1.25 % 
(0.6296 
1.25 % 
(0.6311 g) 
90 % 
(45.4848 g) 
5 16 70 5 % 
(2.5013 g) 
5 % 
(2.4220 
0 0 90 % 
(44.5782 g) 
4 17 84 0 0 0 10 % 
(5.0080 g) 
90 % 
(45.4720 g) 
18 18 101 1.25 % 
(0.6334 g) 
1.25 % 
(0.6265 
6.25 % 
(3.1420 
1.25 % 
(0.6217 g) 
90 % 
(44.749 g) 
22 19 151 0 10 % 
(5.0181 
0 0 90 % 
(45.4232 g) 
6 20 37 5 % 
(2.5595 g) 
0 5 % 
(2.5066 
0 90 % 
(44.7134 g) 
19 21 68 1.25 % 
(0.6351 g) 
1.25 % 
(0.6365 
1.25 % 
(0.6292 
6.25 % 
(3.122 g) 
90 % 
(46.0702 g) 
1 22 43 10 % 
(5.0108 g) 
0 0 0 90 % 
(44.6734 g) 
20 23 57 0 0 0 10 % 
(4.9636 g) 
90 % 
(45.2340 g) 
21 24 75 10 % 
(4.9967 g) 
0 0 0 90 % 
(44.8796 g) 
 
 
The results of the design was analysed by Multiple Least Squares methods using 
Excel software and the following quadratic model was constructed: 
 
 
  Response  = 54.54 x  A + 159.80 x  B + 275.86 x  C + 66.53 x D -56.48 x AB - 
472.03 x AC + 22.95 x AD - 180.51 x BC + 155.56 x BD - 275.99 x CD 
 
In the above model, A = p-menthane-3,8-diol, B = dimethl phtalate, C = benzyl 
benzoate, and D = 2-butyl-2-ethyl-1,3-propanediol. The terms AB, AC, etc. 
represent the interaction (synergism) between actives. The numerical coefficients 
in the model give an indication of the magnitude of the influence of that particular 
active, or combination of actives. It must be noted that in the present model, 
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lower score values are desirable (less bites). Before using the results of the 
model developed from the results of the efficacy tests, it was necessary to 
confirm that the model was statistically valid. This was done by means of an 
Analysis of Variance (ANOVA). Table 3.5 summarises the results of this analysis. 
 
Table 3.5: Anova for Mixture Quadratic Model 
 
Source 
Sum of 
Squares 
DF 
Mean 
Square 
F 
Value 
Prob > F 
Model 93868 9 10429.8 10.2334 < 0.0001 
Residual 14268.6 14 1019.19   
Lack of 
Fit 
10175.1 9 1130.57 1.38093 0.3778 
Pure Error 4093.5 5 818.7   
 
The above analysis shows that the model explains more than 99% of the 
variation in the results obtained, and hence the model is statistically valid and 
can be used for interpretation of the results, as well as prediction of possible 
optimum formulations. 
 
Careful analysis of the above Quadratic model shows that: 
Ø p-Menthane-3,8-diol and 2-butyl-2-ethyl-1,3-propanediol are the most 
effective as single active formulations; 
Ø Benzyl benzoate is the worst single repellent active; 
Ø There is very strong synergism between p-menthane-3,8-diol and benzyl 
benzoate (negative value of -472), and also between benzyl benzoate and 
2-butyl-2-ethyl-1,3-propanediol (negative value of -276); 
Ø While there is some synergism between dimethyl phtalate and benzyl 
benzoate, this synergism appears to be negated by antagonism beween 
dimethyl phtalate and 2-butyl-2-ethyl-1,3-propanediol. 
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The above conclusions are clearly supported by contour diagrams constructed by 
plotting the results predicted by inserting arbitrary values for the four variables 
(between 0 and 10%) into the Quadratic model. In each of the diagrams shown, 
one active was set to 0% so that the figures reflect the response in the variaton 
of only three factors.  
 
Figure 3.1: Contour/response surface diagram  
(p-menthane-3,8-diol + dimethyl phtalate + benzyl benzoate) 
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Figure 3.2: Contour/response surface diagram  
(p-menthane-3,8-diol + dimethyl phtalate + 2-butyl-2-ethyl-1,3-propanediol ) 
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Figure 3.3: Contour/response surface diagram  
(p-menthane-3,8-diol + benzyl benzoate + 2-butyl-2-ethyl-1,3-propanediol ) 
DESIGN-EXPERT Plot
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Figure 3.4: Contour/response surface diagram 
(dimethyl phtalate + benzyl benzoate + 2-butyl-2-ethyl-1,3-propanediol ) 
DESIGN-EXPERT Plot
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From the above analyses, we can readily predict that dimethyl phtalate should be 
omitted from the optimum formulation (which is desirable in view of the reported 
toxicity dangers of dimethyl phtalate). Furthermore, p-menthane-3,8-diol should 
be the main constituent with minor amounts of benzyl benzoate and 2-butyl-2-
ethyl-1,3-propanediol. In order to fine-tune a possible final formulation, various 
values were inserted (in coded form) for p-menthane-3,8-diol, benzyl benzoate 
and 2-butyl-2-ethyl-1,3-propanediol into the Quadratic model. The predicted 
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response was calculated and it was noted that the response decreased as the 
active amounts were varied. Table 3.6 illustrates a number (from a much larger 
set of calculations) of these calculations (Note: The value of dimethyl phtalate 
was always set to zero to remove it from the formulation). 
 
Table 3.6: Predicted values of the response as a function of varying 
amounts of p-menthane-3,8-diol (PMD), benzyl benzoate (BB), 
and 2-butyl-2-ethyl-1,3-propanediol (PD). 
 
 
Actual amounts (%) 
 
Coded values 
 
Response 
PMD BB PD PMD BB PD  
10 0 0 1 0 0 54.54 
9.5 0.25 0.25 0.95 0.025 0.025 49.53 
9 0.5 0.5 0.9 0.05 0.05 45.31 
8.5 0.75 0.75 0.85 0.075 0.075 41.86 
8 1 1 0.8 0.1 0.1 39.19 
7.5 1.25 1.25 0.75 0.125 0.125 37.29 
7 1.5 1.5 0.7 0.15 0.15 36.18 
6.5 1.75 1.75 0.65 0.175 0.175 35.84 
6 2 2 0.6 0.2 0.2 36.28 
 
The final combination of actives selected on the basis of these calculations were:  
 
p-menthane-3,8-diol:  70 % 
benzyl benzoate:  15 % 
2-butyl-2-ethyl-1,3-propanediol:  15 % 
 
To confirm that the above combination is an effective repellent for mosquitoes, 
several samples having the above ratio of actives were prepared and tested for 
efficacy. Unfortunately, the results of these tests were not conclusive as the 
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SABS Test House experienced problems with the test mosquitoes. During this 
time, talks were held with Durotek, a Port Elizabeth manufacturing company 
which specialises in biocide formulations. They expressed an interest to become 
involved in the project, particularly since they believed that the slow-release 
carrier medium they were using in their products could also be of benefit to 
products such as insect repellents. Durotek’s formulation pharmacist 
subsequently prepared several new formulations using the final ratio combination 
of actives as defined from the results of the mixture design, the slow-release 
carrier, and also a small amount of flavourant as an enhancer.  
 
In order to determine the best medium for the active combination, various 
samples were thus prepared using either an in-house aqueous cream or an 
alcohol-based solution. All of these samples contained the slow-release carrier 
but only some contained flavourant. Included in the sample batch were two 
samples containing 15 % DEET as active. The samples were tested for efficacy 
using test cages containing 100 mosquitoes, and once an accumulate number of 
5 bites was recorded, the test was terminated. The results of the best replicates 
of these screening tests are summarized in Table 3.7.  
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Table 3.7: Results from efficacy testing 
 
Hours after treatment and total number 
of bites inflicted 
Sample number 
(contents) 
1 hrs 2 hrs 3 hrs 4 hrs 5 hrs 6 hrs 
1 (DEET solution) 0 0 0 1 2 3 
2 (DEET lotion) 0 0 0 0 5  
3 (solution) 2 2 0 3   
4 (lotion) 3 3     
5 (flavourant, solution) 0 0 0 0 4 1 
6 (flavourant, lotion) 0 1 4    
 
The results in the table above clearly show that: 
(i) The inclusion of the slow-release carrier markedly improves the 
efficacy of the repellent formulation; 
(ii) The addition of the flavourant also enhances the efficacy of the 
repellent mixtures; 
(iii) Alcohol-based combinations are more effective than aqueous cream- 
based mixtures; 
(iv) Some of the mixtures tested are as effective as DEET, but contain less 
active (10% as opposed to 15% for DEET). 
 
One problem observed with the new formulations, particularly with samples 
formulated in aqueous cream, was the oxidation of the added flavourant, which 
resulted in the mixtures turning black with time. It was clear that an additional 
addition, namely an antioxidant, would have to be added to the final mixture. In 
order to have some test samples prepared for the upcoming holiday season, it 
was decided to initially concentrate on the alcohol-based formulations as these 
could be readily packaged for distribution to volunteers for field-testing. In order 
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to counteract the observed oxidation of the flavourant, Vitamin E was added to 
these solutions and, provided samples were not overly exposed to air, oxidation 
was practically eliminated. A final sample containing the complete formulation, 
ready for packaging as an aerosol product (Table 3.8, Sample 2), was sent to the 
SABS Test House. The tests were done using, once again, the test cages 
containing 100 mosquitoes. However, the test period was reduced to a one-
minute exposure time. The results of these tests were compared to a sample 
containing no repellent and a commercial insect repellent sample containing 
19.5% DEET (Table 3.8). In view of the good results obtained, 100 aerosol 
samples were packed for distribution to volunteers in real-life field tests. The 
results of these voluntary tests are still outstanding. 
 
Table 3.8: Comparative efficacy testing of aerosol sample 
 
Hours after treatment and total number 
of bites inflicted 
Sample number 
(contents) 
1 hrs 2 hrs 3 hrs 4 hrs 5 hrs 
1 (Lotion, vitamin E) 2 1 1 5  
2 (Solution, vitamin E)) 0 0 4 3 7 
3 (Solution) 0 1 1 5  
4 (DEET, lotion) 0 0 1 2 6 
5 (No repellent) 45     
 
3.4 STABILITY TESTING  
As part of the research, a controlled stability study was undertaken to determine 
how the individual insect repellent actives found in the final combination 
containing insect repellent actives p-menthane-3, 8-diol, benzyl benzoate and 2-
butyl-2-ethyl-1,3-propanediol interact with each other over time at certain 
temperatures. It must be noted that these studies were conducted before 
Durotek’s involvement; hence, these tests reflect the relative stability of the three 
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active compounds in the absence of a medium, slow-release carrier, flavourant 
and antioxidant. 
 
A normal long-term stability study on any pharmaceutical formulation is usually 
done over a five-year period. However, due to time constraints, an accelerated 
time study over one month was conducted at specific storage conditions. An 
increase in temperature causes an increase in the rate of chemical reactions. For 
this reason, increased temperatures are normally used during such accelerated 
stability tests. For pharmaceutical substances, storage at room temperature is 
normally regarded as storing at 150C. However, under accelerated conditions, 
the required temperature must be at least 50C higher [20]. 
 
In, this specific study, the temperature was set at 260C, 380C and 580C. Since 
the nature of the final storage container for the mosquito repellent combination 
had not yet been determined at the time of this study, glass vials with plastic lids 
were used to store the samples for the duration of the stability test. 
 
Each of the formulated samples were sampled and analysed on a weekly basis 
for four weeks. The analyses were performed by injecting known amounts of 
samples in the GC-MS and measuring the % peak area (of the total peak area as 
determined by the GC-MS) for each of the active components (Table 3.9). The 
peak areas for each individual active were then statistically analysed using 
Analysis of Variance (ANOVA) to determine if any significant decomposition or 
interaction had occurred. 
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Table 3.9: GC-MS results showing % peak area  
 
Temperature Sample no. Time 
p-Menthane-3,8-diol T
0 T1 T2 T3 
26OC S1 67 % 62 % 47 % 53 % 
 S2 64 % 72 % 50 % 47 % 
 S3 63 % 67 % 52 % 48 % 
38OC S1 67 % 63 % 61 % 50 % 
 S2 64 % 57 % 68 % 50 % 
 S3 63 % 64 % 62 % 52 % 
58OC S1 67 % 57 % 60 % 50 % 
 S2 64 % 58 % 57 % 52 % 
 S3 63 % 60 % 53 % 51 % 
Benzyl benzoate 
26OC S1 31 % 12 % 32 % 32 % 
 S2 34 % 13 % 30 % 31 % 
 S3 35 % 13 % 29 % 32 % 
38OC S1 31 % 15 % 28 % 36 % 
 S2 34 % 14 % 23 % 31 % 
 S3 35 % 11 % 26 % 29 % 
58OC S1 31 % 14 % 40 % 28 % 
 S2 34 % 14 % 29 % 28 % 
 S3 35 % 13 % 29 % 34 % 
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Table 3.9: continued 
 
2-Butyl-2-ethyl-1,3-propanediol 
26OC S1 2 % 25 % 21 % 15 % 
 S2 2 % 14 % 21 % 22 % 
 S3 2 % 27 % 18 % 16 % 
38OC S1 2 % 22 % 11 % 14 % 
 S2 2 % 29 % 8 % 19 % 
 S3 2 % 25 % 13 % 18 % 
58OC S1 2 % 29 % 0 % 22 % 
 S2 2 % 28 % 14 % 20 % 
 S3 2 % 27 % 18 % 16 % 
 
Table 3.10: ANOVA for p-menthane-3,8-diol 
 
Source 
Sum of 
Squares 
DF 
Mean 
Square 
F 
Value 
P-value F crit 
Sample 93868 2 23.36 2.79402 0.0811 3.4028 
Time 14268.6 3 365.8 43.75083 6.95E-10 3.0088 
Temp 10175.1 6 61.4 7.3387 0.0001 2.5081 
Within 4093.5 24 8.4    
 
Table 3.11: ANOVA for benzyl benzoate  
 
Source 
Sum of 
Squares 
DF 
Mean 
Square 
F 
Value 
P-value F crit 
Sample 11.17 2 5.583 0.7256 0.4943 3.4028 
Time 2287.67 3 762.556 99.105 1.17E-13 3.0088 
Temp 73.5 6 12.25 1.592 0.1927 2.5081 
Within 184.67 24 7.694    
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Table 3.12: ANOVA for 2-butyl-2-ethyl-1, 3-propanediol 
 
Source 
Sum of 
Squares 
DF 
Mean 
Square 
F 
Value 
P-value F crit 
Sample 18.06 2 9.027 0.5652 0.5756 3.4028 
Time 2532.78 3 844.259 52.8579 1.01E-10 3.0088 
Temp 219.06 6 36.509 2.2858 0.06913 2.5082 
Within  24 15.972    
 
Looking at the ANOVA table for p-menthane-3,8-diol (Table 3.10), we find that for 
samples S1, S2 and S3, the calculated value of F, referred to as Flack of fit, is 
smaller than the critical value Fcrit indicating that there is no significant difference 
between these samples. This is to be expected as these samples were all made 
up from the same batch. For the time variable, Flack of fit  > Fcrit, confirming that 
some degradation occurred with time. Also, Flack of fit > Fcrit for temperature, 
indicating that p-menthane-3,8-diol also degrades with increasing temperature. 
For both 2-butyl-2-ethyl-1,3-propanediol and benzyl benzoate, Flack of fit < Fcrit 
when considering the three different samples and when considering the effect of 
temperature. Hence, no significant difference between samples 1, 2 and 3 was 
observed, as expected. These two actives were also found to be stable at 
increased temperatures and time within each period, as indicated by the smaller 
Fcrit values when compared with the Flack of fit for each variable. 
 
The instability of the PMD was investigated. It was found that the particular 
sample of PMD used for these stability tests was not neutralized before isolation 
and contained small amounts of sulphuric acid used as catalyst during the 
synthesis. Proper neutralization should reduce the tendency of PMD to degrade. 
This will, however, need to be confirmed in a new series of stability studies, but 
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this time using the final formulation in its packaging as intended for market 
release. 
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CHAPTER 4 
 
CONCLUSION 
The results obtained from the various efficacy testing studies at the SABS Test 
House in Pretoria confirmed that synergism does exist between the three actives 
p-menthane-3,8-diol, benzyl benzoate and 2-butyl-2-ethyl-1,3-propanediol which 
were then combined in specific ratios to form the final formulation.  
 
The final combination of the actives p-menthane-3,8-diol (70 %), benzyl benzoate 
(15 %) and 2-butyl-2-ethyl-1,3-propanediol (15 %) were made up as a 10 % 
aerosol sample and results compared favourably with that of the commercial 
samples containing 19.5 % DEET as active. This shows that, by using multiple 
actives in an insect repellent product, it is possible to decrease the amount of 
active used due to the additive effect of the combination. There are a number of 
advantages to this approach that could give such formulations a competitive 
edge over existing products. These include: 
Ø A safer product due to the considerably lower levels of actives; 
Ø A more effective, longer lasting product; 
Ø The ability to formulate insect repellent consumer products that were 
previously not possible due to the lower levels of actives required. 
 
However, before any insect repellent product may be marketed for human use, a 
product application needs to be submitted to the Medical Control Council for 
approval as stated in Act 101 of 1965. This stringent and costly control measure 
prevents many companies from researching alternative insect repellent actives 
with the view to replacing the existing ones (e.g. DEET, DMP), regardless of the 
health risks involved in the use of these products. It would be particularly difficult 
for the PE Technikon, the owner of the intellectual property described in this 
work, to commercialise the IP in view of its status as a tertiary education 
institution. This does not mean that the work described here is only of academic 
interest, and the business proposal (Part B) that follows explores possible 
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avenues for the Technikon from which it may derive commercial benefit from its 
investment in this research.  
 
Certain sections of Part B contain the same information found in Part A, this is 
because when this business proposal is to be presented to the Technikon, Part 
A will not be included. 
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